Cimeio Therapeutics Announces Publication in Nature Demonstrating That CD45 ADC and Shielded HSCs Represent a Potentially Universal Therapy for Blood Cancers
-- Selective and complete eradication of leukemic cells with an ADC targeting the pan-blood marker CD45 -- -- Engineered hematopoietic Stem Cells (HSCs) shielded from the CD45-targeting ADC maintain
Source: finanznachrichten.de
